Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.00
Bid: 107.00
Ask: 109.50
Change: 4.25 (3.94%)
Spread: 2.50 (2.336%)
Open: 109.50
High: 112.00
Low: 109.50
Prev. Close: 107.75
FLO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

5 Jan 2005 07:00

Flomerics Group PLC05 January 2005 5 January 2005 Flomerics Group PLC ("Flomerics" or the "Company") Appointment of Chief Operating Officer The board of Flomerics Group PLC, supplier of analysis software to electronicsindustries, is delighted to announce the appointment of Gary Christopher Carter,aged 45, as Chief Operating Officer with effect from 10 January 2005. It isexpected that Gary will be appointed to the board of Flomerics Group PLC soonafter. As announced in our interim results in July this year, David Tatchell, thecurrent CEO, intends to relinquish the position before he reaches the age of 60in 2006. It is intended that Gary will take over as CEO within this time scale. Gary joins the Company from ANSYS, Inc, a major US-based Computer AidedEngineering ("CAE") company, where he was Managing Director and Vice Presidentof European Sales. David Tatchell, Chief Executive, commented: "Gary has an outstanding 10 year track record in sales leadership and seniormanagement in the CAE industry, and, added to this, brings an in-depthappreciation of the engineering and technical aspects of Flomerics' business.Most importantly, Gary's experience in growing a significantly larger softwareanalysis business will be invaluable to Flomerics in achieving its growthstrategy." Gary Carter commented: "Ever since I first started out in the CAE business, Flomerics has stood out asbeing synonymous with simulation software in the electronics industries. I amtherefore very excited by this opportunity and I am looking forward to workingwith the team that has been behind this success as we address the challenges ofthe future." Mr Carter's current and previous directorships over the past five years are asfollows: Current ANSYS Europe Limited - previously ASN Systems Limited ANSYS France Previous CFX Limited There are no other matters to be disclosed in relation to Schedule 2 paragraph Fof the AIM Rules. For further information please contact: FlomericsDavid Tatchell Chief Executive 020 8941 8810Chris Ogle Finance Director & Company Secretary Buchanan CommunicationsTim Thompson / Nicola Cronk 020 7466 5000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st May 202412:19 pmRNSHolding(s) in Company
22nd May 20246:03 pmRNSHolding(s) in Company
22nd May 20247:00 amRNSExercise of Warrant, Issue of new shares & TVR
20th May 20247:00 amRNSExercise of Options and Total Voting Rights
17th May 20242:54 pmRNSNotice of AGM
9th May 20247:00 amRNSAnnual Financial Report
1st May 20247:00 amRNSHolding(s) in Company
18th Apr 20244:10 pmRNSDirector/PDMR Shareholding
27th Mar 20242:28 pmRNSClarification note regarding Dividend - REPLACE
26th Mar 20247:16 amRNS2023 Annual Unaudited Results
25th Mar 202411:44 amRNSNotice of Results
1st Feb 202410:38 amRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSTrading update
19th Dec 20237:00 amRNSHolding(s) in Company
25th Oct 202311:42 amRNSHolding(s) in Company
31st Aug 20234:25 pmRNSBoard Update
31st Aug 20237:00 amRNSPDMRs - Director Dealings
30th Aug 20237:00 amRNS2023 Half-year report
31st Jul 20237:00 amRNSTrading update & Notice of Half-year results
13th Jun 20231:42 pmRNSResult of AGM
5th Jun 20237:00 amRNSAwards under Long-Term Incentive Plan
5th Jun 20237:00 amRNSBoard update
19th May 20237:00 amRNSAvailability of Documents & Notice of 2023 AGM
15th May 20237:00 amRNSDirector Dealing
26th Apr 20237:01 amRNSAudited Annual Financial Report FY2022
12th Apr 20237:00 amRNSDirectorate Change
12th Apr 20237:00 amRNSUnaudited Preliminary Results-year ended 31.12.22
24th Mar 20237:00 amRNSNotice of Results - revised date
9th Mar 20238:00 amRNSAnnual Results and Presentation via IMC Platform
26th Jan 20237:00 amRNSTrading Update and Notice of Results
11th Jan 20237:00 amRNSBoard changes: NED Appointment & NED Retirement
21st Dec 20224:39 pmRNSHolding(s) in Company
31st Aug 20227:00 amRNSHalf-year Report - six months ended 30 June 2022
8th Aug 20226:27 pmRNSHolding(s) in Company
4th Aug 20227:30 amRNS2022 Half-Year Results - Investor Presentation
1st Aug 20227:00 amRNSGroup Trading Update & Notice of HY1 2022 results
21st Jul 20221:03 pmRNSHolding(s) in Company
1st Jun 20222:23 pmRNSResult of AGM and Total Voting Rights
18th May 20227:00 amRNSDirector/PDMR Shareholding
5th May 20222:20 pmRNS2021 Annual Report & Notice of 2022 AGM
3rd May 20227:00 amRNSGrant of Options under Long-Term Incentive Plan
30th Mar 20221:21 pmRNSDirector/PDMR Shareholding
29th Mar 20227:00 amRNSFY2021 Results & publication of the Annual Report
25th Mar 20225:36 pmRNSHolding(s) in Company
7th Mar 20229:00 amRNSNotice of Results and Investor Presentation
21st Feb 20225:49 pmRNSHolding(s) in Company
26th Jan 20227:01 amRNSTrading Statement
26th Jan 20227:00 amRNSAppointment of Nominated Adviser and Sole Broker
20th Jan 20224:41 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.